[Federal Register Volume 89, Number 40 (Wednesday, February 28, 2024)]
[Notices]
[Page 14671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04115]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, PAR-
22-102 and PAR-22-103: Investigational New Drug (IND)--enabling and 
Early-Stage Development of Medications to Treat Alcohol Use Disorder 
and Alcohol-Associated Organ Damage March 21, 2024, 01:00 p.m. to March 
21, 2024, 04:00 p.m., National Institute of Health, National Institute 
on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892 which was published in the Federal Register on February 01, 2024, 
FR Doc 2024-01998, 89 FR 6530.
    This notice is being amended to change the Meeting Format from a 
Regular Meeting to a Virtual Meeting. The meeting is closed to the 
public.

    Dated: February 21, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-04115 Filed 2-27-24; 8:45 am]
BILLING CODE 4140-01-P